NCIt definition : A humanized monoclonal antibody (MoAb) against human epidermal growth factor receptor
(EGFR) with antineoplastic activity. Depatuxizumab targets the EGFR deletion variant,
de2-7 EGFR as well as wild-type EGFR expressed in cells overexpressing the receptor,
thereby preventing the activation and subsequent dimerization of the receptor; the
decrease in receptor activation and dimerization result in an inhibition in signal
transduction and anti-proliferative effects. This MoAb targets cells expressing aberrant
EGFR, hence making it an ideal candidate for generation of radioisotope or toxin conjugates.;
UNII : W984C353CG;
CAS number : 1471999-69-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1471999-69-5
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;